Stocks Under Consideration: TriQuint Semiconductor(NASDAQ:TQNT), Green …

January 19, 2014 by  
Filed under Solar Energy Tips

Manhattan, NY — (SBWIRE) — 01/18/2014 — concentrates on value small and micro-cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 per share and offer the utmost potential profit on your short or long-term investment.

To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word “PROALERTS” to “555888″. brings you the most vibrant coverage of these stocks: TriQuint Semiconductor(NASDAQ:TQNT), Green Plains Renewable Energy Inc.(NASDAQ:GPRE), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Cvent Inc(NYSE:CVT).

TriQuint Semiconductor(NASDAQ:TQNT), ended higher3.29 % and complete the day at $8.80. The total number of shares changed hands during the day was 160.61 million. After opening at $8.60, the stock hit as high as $8.85. However, it traded between $4.31 and $8.98 over the last twelve months. TriQuint Semiconductor, Inc. provides radio frequency (RF) solutions and technology for mobile device, network infrastructure, and defense and aerospace markets worldwide.

For How Long TriQuint Semiconductor will Fight for Profitability? Read This Trend Analysis report

Green Plains Renewable Energy Inc.(NASDAQ:GPRE), closed at $21.16, a 2.32% increase. Around 2.90 million shares were traded, more than an-average trading volume of 968,918 shares. The company is now valued at around $644.90 million. Green Plains Renewable Energy, Inc. engages in the production, marketing, and distribution of ethanol in the United States.

For How Long GPRE’s Gloss will Attract Investors? Find out via this report

Halozyme Therapeutics, Inc. (NASDAQ:HALO), moved -1.10 percent lower at $17.03 and traded between $16.93 and $18.10after opening the day at $17.28. Its performance over the last five days remained 3.59%, which stands at 15.46% for a month. Going back further than one month, 1-year performance after recent close was 13.61%.Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes.

Why Should Investors Buy HALO After the Recent Fall? Just Go Here and Find Out

Cvent Inc(NYSE:CVT)’s shares loses -1.68 percent to close at $36.27. The stock is down around -0.33% this year and 10.48% for the last 12 months. Around 2.86 million shares changed hands yesterday, higher from an-average trading volume of 114,588 shares. Cvent, Inc., a cloud-based company, provides various solutions for events and meetings value chain primarily in North America.

-Will CVT Get Buyers Even After The Recent Rally? Find Out Here

About Pro Stock Alerts
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word “PROALERTS” to “555888″. is your number one source for the hottest stock tips and picks. We provide short term trading set up alerts as well as long term dividend plays. We also focus on helping you understand the overall market situation so you can use this knowledge in order to gain a better perception during your stock picking decisions.

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.

Neither, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company.

Please read our full disclaimer at:

Comments are closed.